Predefined Single-Use Production Platforms for Biomanufacturing
The biopharmaceutical industry can reduce the time and cost required to bring products to the clinic and the market by taking advantage of single-use production platforms. These platforms integrate proven services and technologies for the development and manufacture of mAbs, vaccines, and bioconjugates.
Companies can streamline early-stage process development activities by leveraging the expertise and experience Sartorius has acquired over many years while establishing biomanufacturing processes for clients. Furthermore, Sartorius can expedite the engineering of single-use and hybrid processes for scale-up during late-stage activities using process templates that reduce design costs and increase standardization.
